Medical Research
-
Jian-Hong Fang & Shi-Mei Zhuang's group identifies a novel mitochondrial micropeptide associated with liver cancer metastasis
A large number of small open reading frames (sORFs) are predicted to exist in the transcripts previously annotated as non-coding RNAs or untranslated regions of protein-coding genes. Emerging evidence show that sORFs may encode micropeptides with less than 100 amino acids. To date, only a small fraction of the putative micropeptides has been functionally characterized. More extensive investigat...
December 30, 2022
-
Professor Mong-Hong Lee and Dr. Qingxin Liu's group discovered new target for colorectal cancer intervention
Colorectal cancer (CRC) is a genetic disease with accumulated genetic alterations during the progression and invasion. CRC is highly aggressive and is the third leading malignance in the world population, and its incidence has been a health care challenge. Thus, there is an urgent need to identify more molecular biomarkers for CRC. Also, it is critical to explore the molecular mechanisms involv...
December 21, 2022
-
Prof. Bin Wu's team revealed a key mechanism of aerobic glycolysis in the process of hepatitis B virus-related HCC
Aerobic glycolysis is considered a hallmark feature of cancer. Recently, Prof. Bin Wu's team from the Third Affiliated Hospital of Sun Yat-sen University published an original article entitled "Aerobic glycolysis enhances HBx-initiated hepatocellular carcinoma via NF-κBp65/HK2 signaling" online in the Journal of Experimental & Clinical Cancer Research on Nov. 21th, revealed a key mechanism of ...
December 6, 2022
-
The research team of Prof. Shicheng Su revealed a new mechanism of the pro-tumor effect mediated by Fcγ receptor signals in non-leukocyte cells
Recently, the research team directed by Prof. Shicheng Su from Sun Yat-sen Memorial Hospital, Sun Yat-sen University, revealed a new mechanism of the pro-tumor effect mediated by Fcγ receptor signals in non-leukocyte cells. This work entitled "CD16+ Fibroblasts Foster a Trastuzumab-Refractory Microenvironment That is Reversed by VAV2 Inhibition" was published online in Cancer Cell on Nov. 14th.
November 24, 2022
-
Prof. Kuang Ming's team and Prof. Lin Shuibin's team co-published an article on intrahepatic cholangiocarcinoma immunotherapy
Recently, Prof. Kuang Ming's team (Center for Hepato-Pancreato-Biliary Surgery, The First Affiliated Hospital, Sun Yat-sen University) and Prof. Lin Shuibin's team (Institute of Precision Medicine, The First Affiliated Hospital, Sun Yat-sen University) co-published a research article entitled “Targeting tumor-intrinsic N7-methylguanosine tRNA modification inhibits MDSC recruitment and improves...
November 8, 2022